Evidence map›Paper›PMID 40735836›Full record

ArticleInternational journal of epidemiology2025

Data Resource Profile: EULAT Eradicate GBC: the European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer.

Dominique Scherer, Carol Barahona Ponce, Claudio Mengoa, Paola Montenegro, Hector Losada, Ana Lineth Garcia, Armando Rojas, Erik Morales, Allan Vera Kortmann, Loreto Spencer and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Dominique SchererStatistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-4430-296X
Carol Barahona PonceStatistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Claudio MengoaInstituto Regional de Enfermedades Neoplásicas, Arequipa, Peru.
Paola MontenegroDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Hector LosadaDepartamento de Cirugía, Universidad de la Frontera, Temuco, Chile.
Ana Lineth GarciaInstituto de Investigaciones Biomédicas (IIBISMED), Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia.
Armando RojasFacultad de Medicina, Universidad Católica del Maule, Talca, Chile.
Erik MoralesFacultad de Medicina, Universidad Católica del Maule, Talca, Chile.
Allan Vera KortmannHospital de Puerto Montt, Los Lagos, Puerto Montt, Chile.
Loreto SpencerHospital Clinico Regional Concepción, Concepción, Chile.
Alejandro OrtegaHospital Juan Noé Crevani, Arica, Chile.
Karina Vargas ValdebenitoHospital Juan Noé Crevani, Arica, Chile.
Juan Carlos RoaCenter for Cancer Prevention and Control (CECAN), Chile.
Cristina InklemonaHospital Pablo Soria, San Salvador de Jujuy, Argentina.
Alicia Colombo FloresCenter for Cancer Prevention and Control (CECAN), Chile.
Romy KirstenUniversity Hospital Mannheim, Medicial Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Linda ZollnerStatistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Katherine MarcelainCenter for Cancer Prevention and Control (CECAN), Chile.
Trine B RoungeCentre for Bioinformatics, Department of Pharmacy, University of Oslo, Oslo, Norway.
Hilde LangsethDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Sarah Jane LewisDepartment of Population Health Sciences, University of Bristol, Bristol, United Kingdom.ORCID 0000-0003-4311-6890
Gerardo Francisco ArroyoILOGI (Latin-American Gastrointestinal Oncology Intergroup), San Salvador de Jujuy, Argentina.
Ricardo ArmisenCentro de Genética y Genómica, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Bruno Nervi NatteroCenter for Cancer Prevention and Control (CECAN), Chile.
Bettina G MullerChilean Cooperative Group for Oncological Research (GOCCHI), Santiago, Chile.
Piga Roxana Fernández KaempfferFundación GIST Chile, Santiago, Chile.
Rajiv KumarStatistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Pamela Salinas-AlvarezInstituto de Alta Investigación, Universidad de Tarapacá, Arica, Chile.
Rachel Sabine KellyChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.ORCID 0000-0003-3023-1822
Mazda JenabNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Justo Lorenzo BermejoStatistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-6568-5333

Funding

European Union's Horizon 2020 research and innovation program 825741World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biorepositorygallbladder cancerpersonalized preventionrisk prediction

Identifiers

PMID40735836
PMCPMC12308174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.